Jenoptik reports ‘record’ second quarter trading figures - IDEX Health & ScienceIDEX Health & Science

    Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Jenoptik reports ‘record’ second quarter trading figures

    Article obtained from Optics.org RSS Feed.

    Revenue up 29.6% in second quarter of 2021; first half-year revenue up 18.3% to €389 million; full year’s forecast raised.

    READ MORE
    Aug, 12 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.